Accéder au contenu
MilliporeSigma

Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer.

Genes & development (2016-03-19)
Nicolas Reynoird, Pawel K Mazur, Timo Stellfeld, Natasha M Flores, Shane M Lofgren, Scott M Carlson, Elisabeth Brambilla, Pierre Hainaut, Ewa B Kaznowska, Cheryl H Arrowsmith, Purvesh Khatri, Carlo Stresemann, Or Gozani, Julien Sage
RÉSUMÉ

Pancreatic ductal adenocarcinoma (PDAC) is a lethal form of cancer with few therapeutic options. We found that levels of the lysine methyltransferase SMYD2 (SET and MYND domain 2) are elevated in PDAC and that genetic and pharmacological inhibition of SMYD2 restricts PDAC growth. We further identified the stress response kinase MAPKAPK3 (MK3) as a new physiologic substrate of SMYD2 in PDAC cells. Inhibition of MAPKAPK3 impedes PDAC growth, identifying a potential new kinase target in PDAC. Finally, we show that inhibition of SMYD2 cooperates with standard chemotherapy to treat PDAC cells and tumors. These findings uncover a pivotal role for SMYD2 in promoting pancreatic cancer.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps monoclonal anti-β-actine antibody produced in mouse, clone AC-74, ascites fluid
Le tarif et la disponibilité ne sont pas disponibles actuellement.
Sigma-Aldrich
Anticorps anti-phospho-histone H3 (Ser10), marqueur mitotique, Upstate®, from rabbit
Le tarif et la disponibilité ne sont pas disponibles actuellement.
Sigma-Aldrich
Monoclonal Anti-AMY1A antibody produced in mouse, clone 2D4, purified immunoglobulin, buffered aqueous solution
Le tarif et la disponibilité ne sont pas disponibles actuellement.
Sigma-Aldrich
Anti-SMYD2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Le tarif et la disponibilité ne sont pas disponibles actuellement.